LA JOLLA PHARMACEUTICAL CO (LJPC) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenue
Revenue
Total revenue	75.7	33.4	23.1	10.1		0.6	1.1
Total revenue growth	126.6%	45.0%	129.3%		-100.0%	-41.7%		-100.0%
Operating expenses
Cost of product sales, license revenue
Selling, general and administrative	35.4	38.4	45.1	85.2	30.9	16.7
Research and development	5.0	23.0	85.3	117.3	86.2	62.8	29.1	9.9
Total operating expenses	53.9	69.3	132.9	204.1	232.5	158.5	86.9	43.2
(Loss) income from operations	21.8	-35.8	-109.8	-194.1	-115.4	-78.4	-42.0	-21.3
Operating margin	28.8%	-107.2%	-476.3%	-1929.7%		-12722.7%	-3970.6%

Other income (expense)
Interest expense	-10.5	-10.1	-10.8	7.3
Other income—related party	7.6	6.3	1.9
Other (expense) income	0.7	0.0			0.6	0.2	0.1	0.0
Total other income (expense), net	-12.6	-13.4	-15.4	3.8	0.6	0.2
Income before income taxes	19.7	-39.4
Provision for income taxes	0.0
Net income	19.7	-39.4	-116.5	-199.5	-114.8	-78.2	-41.9	-21.3

Earnings per share
Basic	$0.72	($1.44)	($4.30)	($7.85)	($5.41)	($4.54)	($2.68)	($2.00)
Diluted	$0.58	($1.44)	($4.30)	($7.85)	($5.41)	($4.54)	($2.68)	($2.00)

Shares used in computing earnings per share
Basic	27.4	27.3	27.1	25.4	21.2	17.2	15.7	10.7
Diluted	34.2	27.3	27.1	25.4	21.2	17.2	15.7	10.7